JPMorgan Chase & Co. Acquires 147,784 Shares of Nu Skin Enterprises, Inc. (NYSE:NUS)

JPMorgan Chase & Co. raised its holdings in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 175.6% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 231,957 shares of the company’s stock after purchasing an additional 147,784 shares during the quarter. JPMorgan Chase & Co.’s holdings in Nu Skin Enterprises were worth $1,710,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Canada Pension Plan Investment Board bought a new stake in Nu Skin Enterprises during the 2nd quarter valued at $47,000. Dark Forest Capital Management LP bought a new stake in Nu Skin Enterprises during the 2nd quarter valued at $106,000. Covestor Ltd increased its stake in Nu Skin Enterprises by 110.9% during the 3rd quarter. Covestor Ltd now owns 10,140 shares of the company’s stock valued at $75,000 after purchasing an additional 5,333 shares in the last quarter. Gladius Capital Management LP bought a new stake in Nu Skin Enterprises during the 3rd quarter valued at $77,000. Finally, Versor Investments LP bought a new stake in Nu Skin Enterprises during the 3rd quarter valued at $86,000. Institutional investors own 82.84% of the company’s stock.

Nu Skin Enterprises Stock Performance

NYSE NUS opened at $7.03 on Thursday. Nu Skin Enterprises, Inc. has a 1 year low of $5.95 and a 1 year high of $19.30. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.93 and a quick ratio of 1.20. The firm has a market cap of $349.21 million, a price-to-earnings ratio of -3.39 and a beta of 1.19. The company has a fifty day moving average price of $7.18 and a 200-day moving average price of $7.90.

Nu Skin Enterprises (NYSE:NUS) last posted its earnings results on Thursday, November 7th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.20 by ($0.03). The firm had revenue of $430.15 million during the quarter, compared to the consensus estimate of $444.10 million. Nu Skin Enterprises had a positive return on equity of 5.47% and a negative net margin of 5.81%. During the same quarter in the previous year, the company earned $0.56 EPS. As a group, equities research analysts predict that Nu Skin Enterprises, Inc. will post 0.68 EPS for the current fiscal year.

Nu Skin Enterprises Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, December 11th. Investors of record on Friday, November 29th were issued a $0.06 dividend. This represents a $0.24 dividend on an annualized basis and a dividend yield of 3.42%. The ex-dividend date of this dividend was Friday, November 29th. Nu Skin Enterprises’s dividend payout ratio (DPR) is currently -11.59%.

Wall Street Analyst Weigh In

A number of brokerages have commented on NUS. DA Davidson decreased their price target on shares of Nu Skin Enterprises from $11.00 to $7.00 and set a “neutral” rating for the company in a research note on Friday, December 20th. StockNews.com upgraded shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Monday, November 11th. Finally, Citigroup reduced their target price on shares of Nu Skin Enterprises from $11.50 to $6.75 and set a “neutral” rating for the company in a research note on Tuesday, October 22nd.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.